Viewing nowMetformin Tablet (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 200301790 · Notified 2003.12.24 · Insurance code 653800580
Treatment of type 2 diabetes mellitus
This medication is used for the treatment of patients with Type 2 diabetes whose blood sugar control is insufficient with diet and exercise alone. It is particularly effective in overweight adult patients and can be used as monotherapy or in combination with other oral hypoglycemic agents or insulin. Additionally, it can be used in children aged 10 years and over as monotherapy or together with insulin, aiding in diabetes management regardless of age. This medication is used to effectively control blood sugar, improving and managing the symptoms of diabetes.
The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. This medication must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses per day, taken in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. At initiation of treatment and when adjusting the dose, fasting blood glucose should be measured to assess the response to this medication and identify the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this medication, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose had been controlled with dietary therapy alone, short-term administration of this medication may be sufficient to achieve an adequate effect. This medication may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, this medication must be discontinued immediately.
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after 1 week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.
This medication can cause severe lactic acidosis or hypoglycemia, so if these symptoms occur, immediate consultation with a healthcare professional is necessary. It should not be administered to patients with moderate to severe renal impairment or those in acute conditions such as dehydration, serious infections, or acute myocardial infarction. It is also not safe to use in patients with acute and unstable heart failure. Before and after examinations using iodinated contrast media, the administration of this medication should be temporarily suspended, and it should be restarted only after renal function has normalized. Patients allergic to this drug or other biguanides should avoid its use. Insulin treatment is necessary for patients with Type 1 diabetes or diabetic ketoacidosis, as this medication is not appropriate for them. Following severe infections or major trauma, the administration of this medication should be temporarily suspended until oral intake becomes possible. Scheduled surgical patients should also stop this medication 48 hours before surgery and resume it only after renal function is confirmed to be normal. Patients who are malnourished or frail, as well as those with pituitary or adrenal insufficiency, should use this product cautiously. Patients with liver dysfunction, severe pulmonary dysfunction, or those who consume excessive alcohol should avoid this medication. Patients with irregular meals or engaging in vigorous exercise, or those who may have interactions with other medications, should be administered this medication with caution. This medication commonly causes gastrointestinal side effects, which may initially include diarrhea, nausea, vomiting, etc., but these are mostly transient. Lactic acidosis is a very rare but dangerous side effect; if symptoms such as weakness, muscle pain, difficulty breathing, or abdominal pain occur, immediate discontinuation of treatment and notification of healthcare professionals is required. Regular renal function tests should be performed to prevent drug accumulation, and elderly patients or those with renal impairment should be particularly cautious. Since alcohol intake can increase the risk of lactic acidosis, excessive drinking should be avoided while taking this medication. B12 vitamin deficiency can occur, so regular monitoring of serum vitamin B12 levels is recommended. During pregnancy, there may be effects on the fetus; therefore, those planning to become pregnant or who are pregnant should consult a physician. In breastfeeding cases, this medication is secreted in breast milk; thus, the decision to continue breastfeeding should be made in consultation with a physician. Interactions may occur with other antidiabetic agents or various medications, so any other medications taken must be reported to healthcare professionals. In case of overdose, blood dialysis may be required, so it is essential to adhere strictly to the prescribed dosage and seek immediate medical attention for any abnormal symptoms. This medication helps control blood sugar without weight gain; however, regular monitoring of blood glucose and renal function tests is necessary to confirm treatment efficacy and safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees Celsius. This will help to maintain the drug's efficacy and prevent deterioration.
White round film-coated tablet
100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.